As part of Pilgrim’s efforts to expand its Prepared Foods operations, the company will be introducing a new line of antibiotic-free artisanal chicken sausages, Pilgrim’s CEO Bill Lovette said.

Speaking during the Pilgrim’s second-quarter earnings call on July 28, Lovette revealed its plans for the new raised without antibiotics product – one he said was developed “using extensive consumer participation.”

“These are great-tasting, made with all-natural ingredients and nothing artificial is added,” Lovette said. “They are clean-labeled and minimally processed to meet the needs of today’s consumer.”

Pilgrim’s, during its first-quarter earnings call announced its intent to enter the organic chicken market and to increase its share in the antibiotic-free poultry market, is demonstrating its commitment to increased antibiotic-free production and product diversification with the upcoming chicken sausage product.

“This represents another key differentiation to our diverse portfolio of fresh and value-added chicken products,” Lovette said.

The CEO also advised investors that the diversification of its product portfolio also demonstrates how the company views its Prepared Foods operations as an important source of future earnings growth while lessening the impact of volatile commodity markets.

Pilgrim’s, according to the WATTAgNet Top Poultry Companies Database, is the second largest broiler company in the United States, having processed 141.67 million pounds of ready-to-cook chicken on a weekly basis in 2015. The company is headquartered in Greeley, Colorado.